1887

Abstract

Enteroaggregative (EAEC) is increasingly recognized as a common cause of diarrhoea in healthy, malnourished and immune-deficient adults and children. There is no reproducible non-neonatal animal model for longitudinal studies of disease mechanism or therapy. Using two strains of human-derived EAEC to challenge weaned C57BL/6 mice, we explored an model of EAEC infection in mice, in which disease was monitored quantitatively as the growth rate, stool shedding and tissue burden of organisms; nutritional status was varied, and a new class of therapeutics was assessed. A single oral challenge of EAEC strain 042 resulted in significant growth shortfalls (5–8 % of body weight in 12 days), persistent shedding of micro-organisms in stools [>10 c.f.u. (10 mg stool) for at least 14 days] and intestinal tissue burden [~10 c.f.u. (10 mg tissue) detectable up to 14 days post-challenge]. Moderate malnourishment of mice using a ‘regional basic diet’ containing 7 % protein and reduced fat and micronutrients heightened all parameters of infection. Nitazoxanide in subMIC doses, administered for 3 days at the time of EAEC challenge, lessened growth shortfalls (by >10 % of body weight), stool shedding [by 2–3 logs (10 mg stool)] and tissue burden of organisms (by >75 % in the jejunum and colon). Thus, weaned C57BL/6 mice challenged with EAEC is a convenient, readily inducible model of EAEC infection with three highly quantifiable outcomes in which disease severity is dependent on the nutritional status of the host, and which is modifiable in the presence of inhibitors of pyruvate ferredoxin oxidoreductase such as nitazoxanide.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.046300-0
2013-06-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/62/6/896.html?itemId=/content/journal/jmm/10.1099/jmm.0.046300-0&mimeType=html&fmt=ahah

References

  1. Anderson V. R., Curran M. P. 2007; Nitazoxanide: a review of its use in the treatment of gastrointestinal infections. Drugs 67:1947–1967 [View Article][PubMed]
    [Google Scholar]
  2. Black R. E., Cousens S., Johnson H. L., Lawn J. E., Rudan I., Bassani D. G., Jha P., Campbell H., Walker C. F. other authors 2010; Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 375:1969–1987 [View Article][PubMed]
    [Google Scholar]
  3. Guerrant R. L., Oriá R. B., Moore S. R., Oriá M. O., Lima A. A. 2008; Malnutrition as an enteric infectious disease with long-term effects on child development. Nutr Rev 66:487–505 [View Article][PubMed]
    [Google Scholar]
  4. Harrington S. M., Strauman M. C., Abe C. M., Nataro J. P. 2005; Aggregative adherence fimbriae contribute to the inflammatory response of epithelial cells infected with enteroaggregative Escherichia coli . Cell Microbiol 7:1565–1578 [View Article][PubMed]
    [Google Scholar]
  5. Harrington S. M., Dudley E. G., Nataro J. P. 2006; Pathogenesis of enteroaggregative Escherichia coli infection. FEMS Microbiol Lett 254:12–18 [View Article][PubMed]
    [Google Scholar]
  6. Harrington S. M., Sheikh J., Henderson I. R., Ruiz-Perez F., Cohen P. S., Nataro J. P. 2009; The Pic protease of enteroaggregative Escherichia coli promotes intestinal colonization and growth in the presence of mucin. Infect Immun 77:2465–2473 [View Article][PubMed]
    [Google Scholar]
  7. Huang D. B., Mohanty A., DuPont H. L., Okhuysen P. C., Chiang T. 2006a; A review of an emerging enteric pathogen: enteroaggregative Escherichia coli . J Med Microbiol 55:1303–1311 [View Article][PubMed]
    [Google Scholar]
  8. Huang D. B., Nataro J. P., DuPont H. L., Kamat P. P., Mhatre A. D., Okhuysen P. C., Chiang T. 2006b; Enteroaggregative Escherichia coli is a cause of acute diarrheal illness: a meta-analysis. Clin Infect Dis 43:556–563 [View Article][PubMed]
    [Google Scholar]
  9. Jiang Z. D., Okhuysen P. C., Guo D. C., He R., King T. M., DuPont H. L., Milewicz D. M. 2003; Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region. J Infect Dis 188:506–511 [View Article][PubMed]
    [Google Scholar]
  10. Kermani N. A., Jafari F., Mojarad H. N., Hoseinkhan N., Zali R. 2010; Prevalence and associated factors of persistent diarrhoea in Iranian children admitted to a paediatric hospital. East Mediterr Health J 16:831–836[PubMed]
    [Google Scholar]
  11. Livak K. J., Schmittgen T. D. 2001; Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Δ Δ C( T)) Method. Methods 25:402–408 [View Article][PubMed]
    [Google Scholar]
  12. Mathewson J. J., Johnson P. C., DuPont H. L., Satterwhite T. K., Winsor D. K. 1986; Pathogenicity of enteroadherent Escherichia coli in adult volunteers. J Infect Dis 154:524–527 [View Article][PubMed]
    [Google Scholar]
  13. McAuliffe J. F., Shields D. S., Auxiliadora de Sousa M., Sakell J., Schorling J., Guerrant R. L. 1986; Prolonged and recurring diarrhea in the northeast of Brazil: examination of cases from a community-based study. J Pediatr Gastroenterol Nutr 5:902–906 [View Article][PubMed]
    [Google Scholar]
  14. Mohamed J. A., Huang D. B., Jiang Z. D., DuPont H. L., Nataro J. P., Belkind-Gerson J., Okhuysen P. C. 2007; Association of putative enteroaggregative Escherichia coli virulence genes and biofilm production in isolates from travelers to developing countries. J Clin Microbiol 45:121–126 [View Article][PubMed]
    [Google Scholar]
  15. Nataro J. P. 2005; Enteroaggregative Escherichia coli pathogenesis. Curr Opin Gastroenterol 21:4–8[PubMed]
    [Google Scholar]
  16. Nataro J. P., Kaper J. B. 1998; Diarrheagenic Escherichia coli . Clin Microbiol Rev 11:142–201[PubMed]
    [Google Scholar]
  17. Nataro J. P., Deng Y., Cookson S., Cravioto A., Savarino S. J., Guers L. D., Levine M. M., Tacket C. O. 1995; Heterogeneity of enteroaggregative Escherichia coli virulence demonstrated in volunteers. J Infect Dis 171:465–468 [View Article][PubMed]
    [Google Scholar]
  18. Nataro J. P., Mai V., Johnson J., Blackwelder W. C., Heimer R., Tirrell S., Edberg S. C., Braden C. R., Glenn Morris J. Jr, Hirshon J. M. 2006; Diarrheagenic Escherichia coli infection in Baltimore, Maryland, and New Haven, Connecticut. Clin Infect Dis 43:402–407 [View Article][PubMed]
    [Google Scholar]
  19. Okeke I. N., Nataro J. P. 2001; Enteroaggregative Escherichia coli . Lancet Infect Dis 1:304–313 [View Article][PubMed]
    [Google Scholar]
  20. Opintan J. A., Newman M. J., Ayeh-Kumi P. F., Affrim R., Gepi-Attee R., Sevilleja J. E., Roche J. K., Nataro J. P., Warren C. A., Guerrant R. L. 2010; Pediatric diarrhea in southern Ghana: etiology and association with intestinal inflammation and malnutrition. Am J Trop Med Hyg 83:936–943 [View Article][PubMed]
    [Google Scholar]
  21. Roche J. K., Cabel A., Sevilleja J., Nataro J., Guerrant R. L. 2010; Enteroaggregative Escherichia coli (EAEC) impairs growth while malnutrition worsens EAEC infection: a novel murine model of the infection malnutrition cycle. J Infect Dis 202:506–514 [View Article][PubMed]
    [Google Scholar]
  22. Shah N., DuPont H. L., Ramsey D. J. 2009; Global etiology of travelers’ diarrhea: systematic review from 1973 to the present. Am J Trop Med Hyg 80:609–614[PubMed]
    [Google Scholar]
  23. Shamir E. R., Warthan M., Brown S. P., Nataro J. P., Guerrant R. L., Hoffman P. S. 2010; Nitazoxanide inhibits biofilm production and hemagglutination by enteroaggregative Escherichia coli strains by blocking assembly of AafA fimbriae. Antimicrob Agents Chemother 54:1526–1533 [View Article][PubMed]
    [Google Scholar]
  24. Shazberg G., Wolk M., Schmidt H., Sechter I., Gottesman G., Miron D. 2003; Enteroaggregative Escherichia coli serotype O126 : H27, Israel. Emerg Infect Dis 9:1170–1173 [View Article][PubMed]
    [Google Scholar]
  25. Sheikh J., Czeczulin J. R., Harrington S., Hicks S., Henderson I. R., Le Bouguénec C., Gounon P., Phillips A., Nataro J. P. 2002; A novel dispersin protein in enteroaggregative Escherichia coli . J Clin Invest 110:1329–1337[PubMed] [CrossRef]
    [Google Scholar]
  26. Steiner T. S., Lima A. A., Nataro J. P., Guerrant R. L. 1998; Enteroaggregative Escherichia coli produce intestinal inflammation and growth impairment and cause interleukin-8 release from intestinal epithelial cells. J Infect Dis 177:88–96 [View Article][PubMed]
    [Google Scholar]
  27. Taylor D. N., Bourgeois A. L., Ericsson C. D., Steffen R., Jiang Z. D., Halpern J., Haake R., Dupont H. L. 2006; A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers’ diarrhea. Am J Trop Med Hyg 74:1060–1066[PubMed]
    [Google Scholar]
  28. Teodósio N. R., Lago E. S., Romani S. A., Guedes R. C. 1990; A regional basic diet from northeast Brazil as a dietary model of experimental malnutrition. Arch Latinoam Nutr 40:533–547[PubMed]
    [Google Scholar]
  29. Tzipori S., Montanaro J., Robins-Browne R. M., Vial P., Gibson R., Levine M. M. 1992; Studies with enteroaggregative Escherichia coli in the gnotobiotic piglet gastroenteritis model. Infect Immun 60:5302–5306[PubMed]
    [Google Scholar]
  30. Ueno P. M., Oriá R. B., Maier E. A., Guedes M., de Azevedo O. G., Wu D., Willson T., Hogan S. P., Lima A. A. other authors 2011; Alanyl-glutamine promotes intestinal epithelial cell homeostasis in vitro and in a murine model of weanling undernutrition. Am J Physiol Gastrointest Liver Physiol 301:G612–G622 [View Article][PubMed]
    [Google Scholar]
  31. Vial P. A., Robins-Browne R., Lior H., Prado V., Kaper J. B., Nataro J. P., Maneval D., Elsayed A., Levine M. M. 1988; Characterization of enteroadherent-aggregative Escherichia coli, a putative agent of diarrheal disease. J Infect Dis 158:70–79 [View Article][PubMed]
    [Google Scholar]
  32. Vila J., Vargas M., Henderson I. R., Gascón J., Nataro J. P. 2000; Enteroaggregative Escherichia coli virulence factors in traveler’s diarrhea strains. J Infect Dis 182:1780–1783 [View Article][PubMed]
    [Google Scholar]
  33. Villaseca J. M., Navarro-García F., Mendoza-Hernández G., Nataro J. P., Cravioto A., Eslava C. 2000; Pet toxin from enteroaggregative Escherichia coli produces cellular damage associated with fodrin disruption. Infect Immun 68:5920–5927 [View Article][PubMed]
    [Google Scholar]
  34. Villaseca J. M., Hernández U., Sainz-Espuñes T. R., Rosario C., Eslava C. 2005; Enteroaggregative Escherichia coli an emergent pathogen with different virulence properties. Rev Latinoam Microbiol 47:140–159[PubMed]
    [Google Scholar]
  35. Wakimoto N., Nishi J., Sheikh J., Nataro J. P., Sarantuya J., Iwashita M., Manago K., Tokuda K., Yoshinaga M., Kawano Y. 2004; Quantitative biofilm assay using a microtiter plate to screen for enteroaggregative Escherichia coli . Am J Trop Med Hyg 71:687–690[PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.046300-0
Loading
/content/journal/jmm/10.1099/jmm.0.046300-0
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error